• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Spironolactone Versus Clonidine as a Fourth-Drug Therapy for Resistant Hypertension: The ReHOT Randomized Study (Resistant Hypertension Optimal Treatment).

广告
作者单位: From the Hypertension Unit, Heart Institute-InCor (E.M.K., L.F.D., D.M.A.G.), Hypertension Unit, Renal Division (L.F.D., D.M.), and Laboratory of Genetics and Molecular Medicine, Heart Institute-InCor (A.C.P., J.E.K.), University of Sao Paulo Medical School, Brazil; Division of Cardiology, Federal University of Sergipe, Brazil (J.A.S.B.-F.); Department of Clinical Research, Hospital Universitario Clementino Fraga Filho, Brazil (A.R.N.); Department of Physiological Sciences, Federal University of Espírito Santo, Brazil (J.G.M.); Division of Internal Medicine, Center for Clinical and Epidemiological Research, University Hospital (P.A.L.) and Ribeirao Preto Medical School (F.N.), University of Sao Paulo, Brazil; Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil (C.A.); Division of Nephrology, Department of Medicine (M.C.B.) and Department of Cardiology (A.C.C.C.), Universidade Federal de São Paulo, Brazil; Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil (L.C.B.); Institute of Cardiology, University Cardiology Foundation, Porto Alegre, Brazil (I.C.); Department of Clinical Medicine, Federal University of Pernambuco, Recife, Brazil (H.C.); Department of Cardiology, Universidade Federal do Para, Belem, Brazil (E.A.S.C.); Escola Bahiana de Medicina e Saude Pública, Salvador, Brazil (G.S.F.); Division of Nephrology, Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University, Brazil (R.J.S.F.); Division of Cardiology, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil (F.D.F.); Federal University of Bahia, Salvador, Brazil (A.C.G.); Faculty of Medicine, Federal University of Goias, Goiânia, Brazil (P.C.J.); Department of Cardiology, School of Medicine, Federal University of Sao Paulo, Brazil (C.A.M.); Serviço de Cardiologia do Hospital Universitario Pedro Ernesto da Universidade do Estado do Rio de Janeiro, Brazil (M.E.M.); Department of Medicine, Ouro Preto Federal University, Brazil (R.M.N.); Hospital Universitario Antonio Pedro, Universidade Federal Fluminense, Rio de Janeiro, Brazil (A.C.N.); Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil (A.L.P.R.); Department of Cardiology, Federal University of Ceara, Fortaleza, Brazil (C.R.-S.); Discipline of Clinical and Experimental Pathophysiology, Rio de Janeiro State University, Brazil (A.F.S.); and Universidade Estadual de Ciencias da Saude de Alagoas, Maceio, Brazil (M.d.C.B.T.). eduardo.krieger@incor.usp.br. [1] From the Hypertension Unit, Heart Institute-InCor (E.M.K., L.F.D., D.M.A.G.), Hypertension Unit, Renal Division (L.F.D., D.M.), and Laboratory of Genetics and Molecular Medicine, Heart Institute-InCor (A.C.P., J.E.K.), University of Sao Paulo Medical School, Brazil; Division of Cardiology, Federal University of Sergipe, Brazil (J.A.S.B.-F.); Department of Clinical Research, Hospital Universitario Clementino Fraga Filho, Brazil (A.R.N.); Department of Physiological Sciences, Federal University of Espírito Santo, Brazil (J.G.M.); Division of Internal Medicine, Center for Clinical and Epidemiological Research, University Hospital (P.A.L.) and Ribeirao Preto Medical School (F.N.), University of Sao Paulo, Brazil; Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil (C.A.); Division of Nephrology, Department of Medicine (M.C.B.) and Department of Cardiology (A.C.C.C.), Universidade Federal de São Paulo, Brazil; Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil (L.C.B.); Institute of Cardiology, University Cardiology Foundation, Porto Alegre, Brazil (I.C.); Department of Clinical Medicine, Federal University of Pernambuco, Recife, Brazil (H.C.); Department of Cardiology, Universidade Federal do Para, Belem, Brazil (E.A.S.C.); Escola Bahiana de Medicina e Saude Pública, Salvador, Brazil (G.S.F.); Division of Nephrology, Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University, Brazil (R.J.S.F.); Division of Cardiology, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil (F.D.F.); Federal University of Bahia, Salvador, Brazil (A.C.G.); Faculty of Medicine, Federal University of Goias, Goiânia, Brazil (P.C.J.); Department of Cardiology, School of Medicine, Federal University of Sao Paulo, Brazil (C.A.M.); Serviço de Cardiologia do Hospital Universitario Pedro Ernesto da Universidade do Estado do Rio de Janeiro, Brazil (M.E.M.); Department of Medicine, Ouro Preto Federal University, Brazil (R.M.N.); Hospital Universitario Antonio Pedro, Universidade Federal Fluminense, Rio de Janeiro, Brazil (A.C.N.); Department of Internal Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil (A.L.P.R.); Department of Cardiology, Federal University of Ceara, Fortaleza, Brazil (C.R.-S.); Discipline of Clinical and Experimental Pathophysiology, Rio de Janeiro State University, Brazil (A.F.S.); and Universidade Estadual de Ciencias da Saude de Alagoas, Maceio, Brazil (M.d.C.B.T.). [2] From the Hypertension Unit, Heart Institute-InCor (E.M.K., L.F.D., D.M.A.G.), Hypertension Unit, Renal Division (L.F.D., D.M.), and Laboratory of Genetics and Molecular Medicine, Heart Institute-InCor (A.C.P., J.E.K.), University of Sao Paulo Medical School, Brazil; Division of Cardiology, Federal University of Sergipe, Brazil (J.A.S.B.-F.); Department of Clinical Research, Hospital Universitario Clementino Fraga Filho, Brazil (A.R.N.); Department of Physiological Sciences, Federal University of Espírito Santo, Brazil (J.G.M.); Division of Internal Medicine, Center for Clinical and Epidemiological Research, University Hospital (P.A.L.) and Ribeirao Preto Medical School (F.N.), University of Sao Paulo, Brazil; Department of Hypertension and Nephrology, Dante Pazzanese Institute of Cardiology, Sao Paulo, Brazil (C.A.); Division of Nephrology, Department of Medicine (M.C.B.) and Department of Cardiology (A.C.C.C.), Universidade Federal de São Paulo, Brazil; Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil (L.C.B.); Institute of Cardiology, University Cardiology Foundation, Porto Alegre, Brazil (I.C.); Department of Clinical Medicine, Federal University of Pernambuco, Recife, Brazil (H.C.); Department of Cardiology, Universidade Federal do Para, Belem, Brazil (E.A.S.C.); Escola Bahiana de Medicina e Saude Pública, Salvador, Brazil (G.S.F.); Division of Nephrology, Department of Internal Medicine, Botucatu Medical School, Sao Paulo State University, Brazil (R.J.S.F.); Division of Cardiology, Hospital de Clinicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil (F.D.F.); Federal University of Bahia, Salvador, Brazil (A.C.G.); Faculty of [3]
DOI 10.1161/HYPERTENSIONAHA.117.10662
PMID 29463627
发布时间 2019-01-23
提交
  • 浏览11
Hypertension (Dallas, Tex. : 1979)

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷